{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:18:27Z","timestamp":1792700307025,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n<jats:title>Abstract<\/jats:title>\n<\/jats:sec><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The emergence of the novel coronavirus in Wuhan, Hubei Province, China, in December 2019 marked the synchronization of the world to a peculiar clock that is counting infected cases and deaths instead of hours and minutes. The pandemic, highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has indeed caused considerable morbidity and mortality and drastically changed our everyday lives. As we continue to become acquainted with the seventh coronavirus known to infect our species, a number of its characteristics keep surprising us. Among those is the wide spectrum of clinical manifestations of the resulting coronavirus disease 2019 (COVID-19), which ranges from asymptomatic or mildly symptomatic infections to severe pneumonia, respiratory failure, and death.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Main body<\/jats:title>\n<jats:p>Data, now from patient populations, are beginning to accumulate on human genetic factors that may contribute to the observed diversified disease severity. Therefore, we deemed it prudent to review the associations between specific human genetic variants and clinical disease severity or susceptibility to infection that have been reported in the literature to date (at the time of writing this article in early August 2020 with updates in mid-September). With this work, we hope (i) to assist the fast-paced biomedical research efforts to combat the virus by critically summarizing current knowledge on the potential role of host genetics, and (ii) to help guide current genetics and genomics research towards candidate gene variants that warrant further investigation in larger studies. We found that determinants of differing severity of COVID-19 predominantly include components of the immune response to the virus, while determinants of differing susceptibility to SARS-CoV-2 mostly entail genes related to the initial stages of infection (i.e., binding of the cell surface receptor and entry).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Elucidating the genetic determinants of COVID-19 severity and susceptibility to SARS-CoV-2 infection would allow for the stratification of individuals according to risk so that those at high risk would be prioritized for immunization, for example, if or when safe and effective vaccines are developed. Our enhanced understanding of the underlying biological mechanisms could also guide personalized therapeutics. Such knowledge is already beginning to provide clues that help explain, at least in part, current epidemiologic observations regarding the typically more severe or benign disease course in older males and children, respectively.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40246-020-00290-4","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T10:02:47Z","timestamp":1603360967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7666-9198","authenticated-orcid":false,"given":"Cleo","family":"Anastassopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Gkizarioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-7776","authenticated-orcid":false,"given":"George P.","family":"Patrinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-4715","authenticated-orcid":false,"given":"Athanasios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"290_CR1","doi-asserted-by":"publisher","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA. 2020;323(20):2052\u20139. https:\/\/doi.org\/10.1001\/jama.2020.6775.","DOI":"10.1001\/jama.2020.6775"},{"key":"290_CR2","doi-asserted-by":"publisher","unstructured":"Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574\u201381. doi.org. https:\/\/doi.org\/10.1001\/jama.2020.5394.","DOI":"10.1001\/jama.2020.5394"},{"key":"290_CR3","doi-asserted-by":"publisher","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan China: a retrospective cohort study. Lancet. 2020;395 (10229):1054\u20131062. doi.org. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"290_CR4","doi-asserted-by":"publisher","unstructured":"Nakeshbandi M, Maini R, Daniel P, et al. The impact of obesity on COVID-19 complications: a retrospective cohort study. Int J Obes. 2020;44(9):1832\u20137. doi.org. https:\/\/doi.org\/10.1038\/s41366-020-0648-x.","DOI":"10.1038\/s41366-020-0648-x"},{"key":"290_CR5","doi-asserted-by":"publisher","unstructured":"Godri Pollitt KJ, Peccia J, Ko AI, et al. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Hum Genomics. 2020;14(1):17. doi.org. https:\/\/doi.org\/10.1186\/s40246-020-00267-3.","DOI":"10.1186\/s40246-020-00267-3"},{"key":"290_CR6","doi-asserted-by":"publisher","unstructured":"LoPresti M, Beck DB, Duggal P, Cummings DAT, Solomon BD. The role of host genetic factors in coronavirus susceptibility: review of animal and systematic review of human literature. Am J Hum Genet. 2020;107(3):381\u2013402. doi.org. https:\/\/doi.org\/10.1016\/j.ajhg.2020.08.007.","DOI":"10.1016\/j.ajhg.2020.08.007"},{"key":"290_CR7","doi-asserted-by":"publisher","unstructured":"Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med. 2020;NEJMoa2020283. doi.org. https:\/\/doi.org\/10.1056\/NEJMoa2020283.","DOI":"10.1056\/NEJMoa2020283"},{"key":"290_CR8","doi-asserted-by":"publisher","unstructured":"Vuille-dit-Bille RN, Camargo SM, Emmenegger L, et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids. 2015;47(4):693\u2013705.\u00a0doi.org. https:\/\/doi.org\/10.1007\/s00726-014-1889-6.","DOI":"10.1007\/s00726-014-1889-6"},{"key":"290_CR9","doi-asserted-by":"publisher","unstructured":"Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128(1):119\u201328. doi.org. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.06.003.","DOI":"10.1016\/j.pharmthera.2010.06.003"},{"key":"290_CR10","doi-asserted-by":"publisher","unstructured":"Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007;25:787\u2013820. doi.org. https:\/\/doi.org\/10.1146\/annurev.immunol.24.021605.090529.","DOI":"10.1146\/annurev.immunol.24.021605.090529"},{"key":"290_CR11","doi-asserted-by":"publisher","unstructured":"Wein AN, McMaster SR, Takamura S, et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J Exp Med. 2019;216(12):2748\u201362. doi.org. https:\/\/doi.org\/10.1084\/jem.20181308.","DOI":"10.1084\/jem.20181308"},{"key":"290_CR12","doi-asserted-by":"publisher","unstructured":"Hickey MJ, Held KS, Baum E, Gao JL, Murphy PM, Lane TE. CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system. Viral Immunol. 2007;20(4):599\u2013608. doi.org. https:\/\/doi.org\/10.1089\/vim.2007.0056.","DOI":"10.1089\/vim.2007.0056"},{"key":"290_CR13","doi-asserted-by":"publisher","unstructured":"Zeberg H, P\u00e4\u00e4bo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020. doi.org. https:\/\/doi.org\/10.1038\/s41586-020-2818-3.","DOI":"10.1038\/s41586-020-2818-3"},{"key":"290_CR14","doi-asserted-by":"publisher","unstructured":"COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet. 2020;28(6):715-8. doi.org. https:\/\/doi.org\/10.1038\/s41431-020-0636-6.","DOI":"10.1038\/s41431-020-0636-6"},{"key":"290_CR15","doi-asserted-by":"publisher","unstructured":"Nguyen A, David JK, Maden SK, et al. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 2020;94(13):e00510\u201320. doi.org. https:\/\/doi.org\/10.1128\/JVI.00510-20.","DOI":"10.1128\/JVI.00510-20"},{"key":"290_CR16","doi-asserted-by":"publisher","unstructured":"Lin M, Tseng H, Trejaut JA, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4:9. doi.org. https:\/\/doi.org\/10.1186\/1471-2350-4-9.","DOI":"10.1186\/1471-2350-4-9"},{"key":"290_CR17","doi-asserted-by":"publisher","unstructured":"Wang F, Huang S, Gao H, et al. Initial whole genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. medRxiv. 2020. doi.org. https:\/\/doi.org\/10.1101\/2020.06.09.20126607.","DOI":"10.1101\/2020.06.09.20126607"},{"key":"290_CR18","doi-asserted-by":"publisher","unstructured":"Novelli A, Andreani M, Biancolella M, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020. doi.org. https:\/\/doi.org\/10.1111\/tan.14047.","DOI":"10.1111\/tan.14047"},{"key":"290_CR19","doi-asserted-by":"publisher","unstructured":"van der Made CI, Simons A, Schuurs-Hoeijmakers J, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324(7):1\u201311. doi.org. https:\/\/doi.org\/10.1001\/jama.2020.13719.","DOI":"10.1001\/jama.2020.13719"},{"key":"290_CR20","doi-asserted-by":"publisher","unstructured":"Casanova J-L, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol. 2011;29:447\u201391. doi.org. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101335.","DOI":"10.1146\/annurev-immunol-030409-101335"},{"key":"290_CR21","doi-asserted-by":"publisher","unstructured":"Cervantes-Barragan L, Z\u00fcst R, Weber F, et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood. 2007;109(3):1131-7. doi.org. https:\/\/doi.org\/10.1182\/blood-2006-05-023770.","DOI":"10.1182\/blood-2006-05-023770"},{"key":"290_CR22","doi-asserted-by":"publisher","unstructured":"Moreno-Eutimio MA, L\u00f3pez-Mac\u00edas C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 2020;22(4-5):226\u20139. doi.org. https:\/\/doi.org\/10.1016\/j.micinf.2020.04.009.","DOI":"10.1016\/j.micinf.2020.04.009"},{"key":"290_CR23","doi-asserted-by":"publisher","unstructured":"Channappanavar R, Fehr AR, Zheng J, et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019;129(9):3625\u201339. doi.org. https:\/\/doi.org\/10.1172\/JCI126363.","DOI":"10.1172\/JCI126363"},{"key":"290_CR24","doi-asserted-by":"publisher","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036\u20131045.e9. doi.org. https:\/\/doi.org\/10.1016\/j.cell.2020.04.026.","DOI":"10.1016\/j.cell.2020.04.026"},{"key":"290_CR25","doi-asserted-by":"publisher","unstructured":"Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, M\u00f6ller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13(1):2. doi.org. https:\/\/doi.org\/10.1186\/s40246-018-0185-z.","DOI":"10.1186\/s40246-018-0185-z"},{"key":"290_CR26","doi-asserted-by":"publisher","unstructured":"Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019;56(3):308\u201321. doi.org. https:\/\/doi.org\/10.1007\/s12016-017-8648-x.","DOI":"10.1007\/s12016-017-8648-x"},{"key":"290_CR27","doi-asserted-by":"publisher","unstructured":"Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9\u201315.\u00a0doi.org. https:\/\/doi.org\/10.1093\/trstmh\/tru167.","DOI":"10.1093\/trstmh\/tru167"},{"key":"290_CR28","doi-asserted-by":"publisher","unstructured":"Souyris M, Mej\u00eda JE, Chaumeil J, Gu\u00e9ry J-C. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin Immunopathol. 2019;41(2):153\u201364. doi.org. https:\/\/doi.org\/10.1007\/s00281-018-0712-y.","DOI":"10.1007\/s00281-018-0712-y"},{"key":"290_CR29","doi-asserted-by":"publisher","unstructured":"Cutolo M, Capellino S, Sulli A, et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006;1089:538-47. doi.org. https:\/\/doi.org\/10.1196\/annals.1386.043.","DOI":"10.1196\/annals.1386.043"},{"key":"290_CR30","doi-asserted-by":"publisher","unstructured":"Atkins JL, Masoli JAH, Delgado J, Et al. Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 2020;glaa183. doi.org. https:\/\/doi.org\/10.1093\/gerona\/glaa183.","DOI":"10.1093\/gerona\/glaa183"},{"key":"290_CR31","doi-asserted-by":"publisher","unstructured":"Kuo CL, Pilling LC, Atkins JL, Kuchel GA, Melzer D.\u00a0ApoE\u00a0e2 and aging-related outcomes in 379,000 UK Biobank participants. Aging (Albany NY). 2020;12(12):12222-33. doi.org. https:\/\/doi.org\/10.18632\/aging.103405.","DOI":"10.18632\/aging.103405"},{"key":"290_CR32","doi-asserted-by":"publisher","unstructured":"Kuo CL, Pilling LC, Atkins JL, Et al. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci. 2020; glaa131. doi.org. https:\/\/doi.org\/10.1093\/gerona\/glaa131.","DOI":"10.1093\/gerona\/glaa131"},{"key":"290_CR33","doi-asserted-by":"publisher","unstructured":"Tudorache IF, Trusca VG, Gafencu AV. Apolipoprotein E - a multifunctional protein with implications in various pathologies as a result of its structural features. Comput Struct Biotechnol J. 2017;15:359\u201365. doi.org. https:\/\/doi.org\/10.1016\/j.csbj.2017.05.003.","DOI":"10.1016\/j.csbj.2017.05.003"},{"key":"290_CR34","doi-asserted-by":"publisher","unstructured":"Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012;484(7395):519\u201323. doi.org. https:\/\/doi.org\/10.1038\/nature10921.","DOI":"10.1038\/nature10921"},{"key":"290_CR35","doi-asserted-by":"publisher","unstructured":"Thevarajan I, Nguyen THO, Koutsakos M, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26(4):453\u20135. doi.org. https:\/\/doi.org\/10.1038\/s41591-020-0819-2.","DOI":"10.1038\/s41591-020-0819-2"},{"key":"290_CR36","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. PNAS. 2014;111(2):769-74. doi.org. https:\/\/doi.org\/10.1073\/pnas.1321748111.","DOI":"10.1073\/pnas.1321748111"},{"key":"290_CR37","doi-asserted-by":"publisher","unstructured":"Cheng Y, Cheng G, Chui CH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA. 2005;293(12):1450\u20131. doi.org.https:\/\/doi.org\/10.1001\/jama.293.12.1450-c.","DOI":"10.1001\/jama.293.12.1450-c"},{"key":"290_CR38","doi-asserted-by":"publisher","unstructured":"Zhao J, Yang Y, Huang H, Et al. Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis. 2020;ciaa1150. doi.org. https:\/\/doi.org\/10.1093\/cid\/ciaa1150.","DOI":"10.1093\/cid\/ciaa1150"},{"key":"290_CR39","doi-asserted-by":"publisher","unstructured":"Wu Y, Feng Z, Li P, Yu Q. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta. 2020;509:220\u20133. doi.org. https:\/\/doi.org\/10.1016\/j.cca.2020.06.026.","DOI":"10.1016\/j.cca.2020.06.026"},{"key":"290_CR40","doi-asserted-by":"publisher","unstructured":"Breiman A, Ruv\u00ebn-Clouet N, Le Pendu J. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2. PLoS Pathog. 2020;16(5):e1008556.\u00a0doi.org. https:\/\/doi.org\/10.1371\/journal.ppat.1008556.","DOI":"10.1371\/journal.ppat.1008556"},{"key":"290_CR41","doi-asserted-by":"publisher","unstructured":"Comuzzie AG, Cole SA, Laston SL, et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 2012;7(12):e51954.\u00a0doi.org. https:\/\/doi.org\/10.1371\/journal.pone.0051954.","DOI":"10.1371\/journal.pone.0051954"},{"key":"290_CR42","doi-asserted-by":"publisher","unstructured":"Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020. doi.org. https:\/\/doi.org\/10.1002\/jmv.25948.","DOI":"10.1002\/jmv.25948"},{"key":"290_CR43","doi-asserted-by":"publisher","unstructured":"Naitza S, Porcu E, Steri M, et al. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet. 2012;8(1):e1002480. doi.org. https:\/\/doi.org\/10.1371\/journal.pgen.1002480.","DOI":"10.1371\/journal.pgen.1002480"},{"key":"290_CR44","doi-asserted-by":"publisher","unstructured":"Franchini M, Crestani S, Frattini F, Sissa C, Bonfanti C. ABO blood group and von Willebrand factor: biological implications. Clin Chem Lab Med. 2014;52(9):1273\u20136. doi.org. https:\/\/doi.org\/10.1515\/cclm-2014-0564.","DOI":"10.1515\/cclm-2014-0564"},{"key":"290_CR45","doi-asserted-by":"publisher","unstructured":"Murray GP, Post SR, Post GR. ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells. J Clin Pathol. 2020;73(6):347\u20139. doi.org. https:\/\/doi.org\/10.1136\/jclinpath-2019-206182.","DOI":"10.1136\/jclinpath-2019-206182"},{"key":"290_CR46","doi-asserted-by":"publisher","unstructured":"Zietz M, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv.\u00a02020;2020.04.08.20058073. doi.org. https:\/\/doi.org\/10.1101\/2020.04.08.20058073.","DOI":"10.1101\/2020.04.08.20058073"},{"key":"290_CR47","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.\u00a0SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8.\u00a0doi.org. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"290_CR48","doi-asserted-by":"publisher","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185\u20132. doi.org. https:\/\/doi.org\/10.1007\/s11684-020-0754-0.","DOI":"10.1007\/s11684-020-0754-0"},{"key":"290_CR49","doi-asserted-by":"publisher","unstructured":"Hou Y, Zhao J, Martin W, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18(1):216. doi.org. https:\/\/doi.org\/10.1186\/s12916-020-01673-z.","DOI":"10.1186\/s12916-020-01673-z"},{"key":"290_CR50","doi-asserted-by":"publisher","unstructured":"Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. 2020;10(6):779\u201382.\u00a0doi.org. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0451.","DOI":"10.1158\/2159-8290.CD-20-0451"},{"key":"290_CR51","doi-asserted-by":"publisher","unstructured":"Vargas-Alarc\u00f3n G, Posadas-S\u00e1nchez R, Ram\u00edrez-Bello J. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Life Sci. 2020;260:118313. doi.org. https:\/\/doi.org\/10.1016\/j.lfs.2020.118313.","DOI":"10.1016\/j.lfs.2020.118313"},{"key":"290_CR52","doi-asserted-by":"publisher","unstructured":"Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108\u201310. doi.org. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0980.","DOI":"10.1001\/jamaoncol.2020.0980"},{"key":"290_CR53","doi-asserted-by":"publisher","unstructured":"Schuler A, Habermann C, Plosa J, et al. Age-related expression of SARS-CoV- 2 primining protease TMPRSS2 in the developing lung. bioRxiv. 2020; 2020.05.22.111187. doi.org. https:\/\/doi.org\/10.1101\/2020.05.22.111187.","DOI":"10.1101\/2020.05.22.111187"},{"key":"290_CR54","doi-asserted-by":"publisher","unstructured":"Mostafavi H, Berisa T, Day FR, Perry JRB, Przeworski M, Pickrell JK. Identifying genetic variants that affect viability in large cohorts. PLoS Biol. 2017;15(9):e2002458.\u00a0doi.org. https:\/\/doi.org\/10.1371\/journal.pbio.2002458.","DOI":"10.1371\/journal.pbio.2002458"},{"key":"290_CR55","doi-asserted-by":"publisher","unstructured":"Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020;12(11):10087\u201398doi.org. https:\/\/doi.org\/10.18632\/aging.103415.","DOI":"10.18632\/aging.103415"},{"key":"290_CR56","doi-asserted-by":"publisher","unstructured":"Benetti E, Tita R, Spiga O, et al. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. Eur J Hum Genet. 2020:1\u201313. doi.org. https:\/\/doi.org\/10.1038\/s41431-020-0691-z.","DOI":"10.1038\/s41431-020-0691-z"},{"key":"290_CR57","doi-asserted-by":"publisher","unstructured":"Novelli A, Biancolella M, Borgiani P, et al. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum Genomics. 2020;14(1):29. doi.org. https:\/\/doi.org\/10.1186\/s40246-020-00279-z.","DOI":"10.1186\/s40246-020-00279-z"},{"key":"290_CR58","doi-asserted-by":"publisher","unstructured":"Latini A, Agolini E, Novelli A, et al. COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. Genes (Basel). 2020;11(9):E1010. doi.org. https:\/\/doi.org\/10.3390\/genes11091010.","DOI":"10.3390\/genes11091010"},{"key":"290_CR59","doi-asserted-by":"publisher","unstructured":"Lee IH, Lee JW, Kong SW. A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3\/7\/8 across populations. Infect Genet Evol. 2020;85:104507. doi.org. https:\/\/doi.org\/10.1016\/j.meegid.2020.104507.","DOI":"10.1016\/j.meegid.2020.104507"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-020-00290-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-020-00290-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-020-00290-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T23:29:06Z","timestamp":1634858946000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-020-00290-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1186\/s40246-020-00290-4","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}